In vitro activity of neomycin, streptomycin, paromomycin and apramycin against carbapenem-resistant Enterobacteriaceae clinical strains

Frontiers in Microbiology

Volumn 8, Issue NOV, 2017, Pages

  Hu, Ya ^a,b   Liu, Lu ^a,b   Zhang, Xiaoxia ^a,b   Feng, Yu ^a,b   Zong, Zhiyong ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Aminoglycosides; Apramycin; Carbapenemase; Enterobacteriaceae; Neomycin; Paromomycin; Streptomycin; Susceptibility

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; APRAMYCIN; GENTAMICIN; NEOMYCIN; PAROMOMYCIN; STREPTOMYCIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; APRAMYCIN RESISTANT GENE; ARTICLE; BACTERIAL STRAIN; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CHINA; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; FOOD AND DRUG ADMINISTRATION; GENE; GENE SEQUENCE; KLEBSIELLA PNEUMONIAE; MIC50; MIC90; MINIMUM INHIBITORY CONCENTRATION; MULTI LOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SANGER SEQUENCING; WHOLE GENOME SEQUENCING;

EID: 85034583104     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.02275     Document Type: Article

References (36)

1. Almaghrabi, R., Clancy, C. J., Doi, Y., Hao, B., Chen, L., Shields, R. K., et al. (2014). Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents. Antimicrob. Agents Chemother. 58, 4443-4451. doi: 10.1128/AAC.00099-14
2. Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., et al. (2012). SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 19, 455-477. doi: 10.1089/cmb.2012.0021
3. Bolger, A. M., Lohse, M., and Usadel, B. (2014). Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120. doi: 10.1093/bioinformatics/btu170
4. Bradford, P. A., Bratu, S., Urban, C., Visalli, M., Mariano, N., Landman, D., et al. (2004). Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 ß-lactamases in New York City. Clin. Infect. Dis. 39, 55-60. doi: 10.1086/421495
5. Buehlmann, M., Bruderer, T., Frei, R., and Widmer, A. F. (2011). Effectiveness of a new decolonisation regimen for eradication of extended-spectrum ß-lactamase-producing Enterobacteriaceae. J. Hosp. Infect. 77, 113-117. doi: 10.1016/j.jhin.2010.09.022
6. Clark, C. H. (1977). Clinical uses of kanamycin, neomycin and streptomycin. Mod. Vet. Pract. 58, 845-850
7. CLSI (2017). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Seven Informational Supplement. M100-S27. Wayne, PA: Clinical and Laboratory Standards Institute
8. Doi, Y., Wachino, J. I., and Arakawa, Y. (2016). Aminoglycoside resistance: the emergence of acquired 16s ribosomal rna methyltransferases. Infect. Dis. Clin. North Am. 30, 523-537. doi: 10.1016/j.idc.2016.02.011
9. Falagas, M. E., Lourida, P., Poulikakos, P., Rafailidis, P. I., and Tansarli, G. S. (2014). Antibiotic treatment of infections due to carbapenem-resistant enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob. Agents Chemother. 58, 654-663. doi: 10.1128/AAC.01222-13
10. Hirsch, E. B., and Tam, V. H. (2010). Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J. Antimicrob. Chemother. 65, 1119-1125. doi: 10.1093/jac/dkq108
11. Huttner, B., Haustein, T., Uckay, I., Renzi, G., Stewardson, A., Schaerrer, D., et al. (2013). Decolonization of intestinal carriage of extended-spectrum ß-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J. Antimicrob. Chemother. 68, 2375-2382. doi: 10.1093/jac/dkt174
12. Iovleva, A., and Doi, Y. (2017). Carbapenem-resistant Enterobacteriaceae. Clin. Lab. Med. 37, 303-315. doi: 10.1016/j.cll.2017.01.005
13. Kang, A. D., Smith, K. P., Eliopoulos, G. M., Berg, A. H., McCoy, C., and Kirby, J. E. (2017). In vitro apramycin activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Diagn. Microbiol. Infect. Dis. 88, 188-191. doi: 10.1016/j.diagmicrobio.2017.03.006
14. Kostrub, C. F., Diokno, R., Aggen, J. B, Miller, G. H., Judice, J. K., and Tulkens, P. (2009). 'Quantitative comparison of aminoglycoside nephrotoxicity in rats for effective screening and evaluation of new derivatives, and dosing rationales that minimise toxicity,' in European Congress of Clinical Microbiology and Infectious Diseases (Helsinki), 1979
15. Livermore, D. M., Mushtaq, S., Warner, M., Zhang, J. C., Maharjan, S., Doumith, M., et al. (2011a). Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J. Antimicrob. Chemother. 66, 48-53. doi: 10.1093/jac/dkq408
16. Livermore, D. M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., and Woodford, N. (2011b). What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int. J. Antimicrob. Agents 37, 415-419. doi: 10.1016/j.ijantimicag.2011.01.012
17. Logan, L. K., and Weinstein, R. A. (2017). The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J. Infect. Dis. 215, S28-S36. doi: 10.1093/infdis/jiw282
18. Matt, T., Ng, C. L., Lang, K., Sha, S. H., Akbergenov, R., Shcherbakov, D., et al. (2012). Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin. Proc. Natl. Acad. Sci. U.S.A. 109, 10984-10989. doi: 10.1073/pnas.1204073109
19. Mendes, R. E., Kiyota, K. A., Monteiro, J., Castanheira, M., Andrade, S. S., Gales, A. C., et al. (2007). Rapid detection and identification of metallo-ß-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J. Clin. Microbiol. 45, 544-547. doi: 10.1128/JCM.01728-06
20. Mingeot-Leclercq, M. P., Glupczynski, Y., and Tulkens, P. M. (1999). Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43, 727-737
21. Perzynski, S., Cannon, M., Cundliffe, E., Chahwala, S. B., and Davies, J. (1979). Effects of apramycin, a novel aminoglycoside antibiotic on bacterial protein synthesis. Eur. J. Biochem. 99, 623-628. doi: 10.1111/j.1432-1033.1979.tb13295.x
22. Poirel, L., Jayol, A., and Nordmann, P. (2017). Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin. Microbiol. Rev. 30, 557-596. doi: 10.1128/CMR.00064-16
23. Poirel, L., Le Thomas, I., Naas, T., Karim, A., and Nordmann, P. (2000). Biochemical sequence analyses of GES-1, a novel class A extended-spectrum ß-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44, 622-632. doi: 10.1128/AAC.44.3.622-632.2000
24. Rafailidis, P. I., and Falagas, M. E. (2014). Options for treating carbapenem-resistant Enterobacteriaceae. Curr. Opin. Infect. Dis. 27, 479-483. doi: 10.1097/QCO.0000000000000109
25. Randall, L., Ridley, A., Lemma, F., Hale, C., and Davies, R. (2016). In vitro investigations into the use of antimicrobials in combination to maintain efficacy of fluoroquinolones in poultry. Res. Vet. Sci. 108, 47-53. doi: 10.1016/j.rvsc.2016.07.010
26. Rieg, S., Kupper, M. F., De With, K., Serr, A., Bohnert, J. A., and Kern, W. V. (2015). Intestinal decolonization of Enterobacteriaceae producing extended-spectrum ß-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature. BMC Infect. Dis. 15, 475. doi: 10.1186/s12879-015-1225-0
27. Shaw, K. J., Rather, P. N., Hare, R. S., and Miller, G. H. (1993). Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57, 138-163
28. Shields, R. K., Clancy, C. J., Press, E. G., and Nguyen, M. H. (2016). Aminoglycosides for treatment of bacteremia due to carbapenem-resistant Klebsiella pneumoniae. Antimicrob. Agents Chemother. 60, 3187-3192. doi: 10.1128/AAC.02638-15
29. Sinha, R. P. (1986). Development of high-level streptomycin resistance affected by a plasmid in lactic streptococci. Appl. Environ. Microbiol. 52, 255-261
30. Smith, K. P., and Kirby, J. E. (2016). Evaluation of apramycin activity against carbapenem-resistant and-susceptible strains of Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 86, 439-441. doi: 10.1016/j.diagmicrobio.2016.09.002
31. Temkin, E., Adler, A., Lerner, A., and Carmeli, Y. (2014). Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann. N.Y. Acad. Sci. 1323, 22-42. doi: 10.1111/nyas.12537
32. Van Duin, D., Kaye, K. S., Neuner, E. A., and Bonomo, R. A. (2013). Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn. Microbiol. Infect. Dis. 75, 115-120. doi: 10.1016/j.diagmicrobio.2012.11.009
33. World Health Organization (2015). WHO Model List of Essential Medicines. Geneva: World Health Organization
34. Zhang, R., Liu, L., Zhou, H., Chan, E. W., Li, J., Fang, Y., et al. (2017). Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine 19, 98-106. doi: 10.1016/j.ebiom.2017.04.032
35. Zhang, X., Lu, X., and Zong, Z. (2012). Enterobacteriaceae producing the KPC-2 carbapenemase from hospital sewage. Diagn. Microbiol. Infect. Dis. 73, 204-206. doi: 10.1016/j.diagmicrobio.2012.02.007
36. Zong, Z., and Zhang, X. (2013). blaNDM-1-carrying Acinetobacter johnsonii detected in hospital sewage. J. Antimicrob. Chemother. 68, 1007-1010. doi: 10.1093/jac/dks505